Last update 01 Nov 2024

JWCAR201

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
Autologous CD19/CD20-directed CAR-T cells(Fudan University)
Target
CD19 x CD20
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators), CD20 modulators(B-lymphocyte antigen CD20 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Large B-cell lymphomaSystemic Lupus ErythematosusDiffuse Large B-Cell Lymphoma
Inactive Indication-
Originator Organization
Fudan UniversityFudan University
Active Organization
Fudan UniversityFudan UniversityShanghai Ming Ju Biotechnology Co. Ltd.Shanghai Ming Ju Biotechnology Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with JWCAR201
NCT06567080 / Not yet recruitingPhase 1IIT
An Open Label, Single Arm Study to Evaluate JWCAR201 Treating B Cell Driven Hematology Malignancy and Autoimmune Diseases
NCT06517004 / RecruitingPhase 1IIT
An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
100 Clinical Results associated with JWCAR201
Login to view more data
100 Translational Medicine associated with JWCAR201
Login to view more data
100 Patents (Medical) associated with JWCAR201
Login to view more data
1
Literatures (Medical) associated with JWCAR201
Blood Cancer Journal
Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial
100 Deals associated with JWCAR201
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Large B-cell lymphomaPhase 1
CN
Shanghai Ming Ju Biotechnology Co. Ltd.Shanghai Ming Ju Biotechnology Co. Ltd.
01 Sep 2024
Systemic Lupus ErythematosusPhase 1
CN
Shanghai Ming Ju Biotechnology Co. Ltd.Shanghai Ming Ju Biotechnology Co. Ltd.
01 Sep 2024
Diffuse Large B-Cell LymphomaPhase 1
CN
Fudan UniversityFudan University
18 Jul 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free